Results 111 to 120 of about 206,766 (202)

Bivalent RSVpreF Subunit Vaccine Safety and Immunogenicity in Seropositive 2-<18 Year Olds. [PDF]

Vaccines (Basel)
Glanternik J, Paulsen GC, Senders S, Smith M, Shittu E, Pahud BA, Pereira L, Chen L, Maddalena Lino M, Kalinina EV, Baranova D, Kalina WV, Needle E, Murillo M, Leech JM, Cooper D, Swanson KA, Anderson AS, Gurtman A, Munjal I.   +19 more
europepmc   +1 more source

Author Correction: Changes in vaccine attitudes and recommendations among US Healthcare Personnel during the COVID-19 pandemic

npj Vaccines
Matthew Z. Dudley, Holly B. Schuh, Amanda Forr, Jana Shaw, Daniel A. Salmon   +4 more
doaj   +1 more source

Harmonizing Case Validation for Vaccine Safety in Real-World Data: The VAC4EU Experience. [PDF]

Clin Epidemiol
Dehghan Tarazjani A, Weibel D, Aurelius T, Zwiers LC, Van den Berg JM, Pérez-Breva L, Gimeno-Miguel A, Stona L, Solórzano M, Desalegn AA, Poblador-Plou B, Lysen TS, Wheler J, Zidan M, Carreras JJ, Villalobos F, Ehrenstein V, Morton K, Rebordosa C, Ahmadizar F, Fortuny J, Arana A, Sturkenboom M.   +22 more
europepmc   +1 more source

What every clinician should know about COVID-19 vaccine safety [PDF]

Date: Monday, December 14Time: 1:00\u20132:00 P.M. ETDue to technical issues, the first few minutes including introductory remarks for the webinar were not recorded.Monitoring vaccine\u202fsafety is a vital part of the nation\u2019s response to the COVID-

core  

Active Surveillance for COVID-19 Vaccine Safety Using Sequential Analysis in Korea: Population-Based Retrospective Observational Study. [PDF]

JMIR Public Health Surveill
Jeong NY, Cho H, Won H, Park S, Lee J, Park H, Choi NK.   +6 more
europepmc   +1 more source

Pregnant Women and Vaccine Safety in Uganda: Knowledge, Barriers, and Opportunities for Engagement. [PDF]

Vaccines (Basel)
Nambasa VP, Komuhendo R, Serwanga A, Kajungu D, Koch BCP, Kampmann B, Le Doare K, Ssali A.   +7 more
europepmc   +1 more source

Understanding adverse events following immunisation: evidence of vaccine safety and coincidental events from 3 years of surveillance. [PDF]

BMJ Paediatr Open
Mathew M, Sanathan SR, Ravi MD.
europepmc   +1 more source

Zimbabwe adverse events following immunisation surveillance system: A descriptive study with COVID-19 vaccine safety updates. [PDF]

S Afr J Infect Dis
Nyambayo PPM, Manyevere R, Chirinda L, Marekera SF, Nyamandi T, Chaitezvi RP, Rukwata RT, Mehta U, Gold MS.   +8 more
europepmc   +1 more source

MMRV vaccine safety: A comprehensive analysis of adverse events recorded among pediatric populations. [PDF]

Hum Vaccin Immunother
Yan K, Yang G, Yan L, Wu R, Wu L, Wang Y, He P, Yu Q.   +7 more
europepmc   +1 more source

Efficacy and safety of vaccines

Veterinary Quarterly, 1994
openaire   +2 more sources